Overview
Brammer Bio is a CDMO focused on providing process development, clinical, and commercial supply of autologous and allogeneic cell therapy, ex vivo gene therapy and viral vector products enabling the delivery of novel medicines and improving patient health. We have a highly skilled team of scientists with the development, manufacturing and analytical expertise required to tackle the challenges posed by these novel technologies and help accelerate their transition from the clinic to patients in need. Brammer Bio is the leading company in its field with the expertise to support your gene and cell therapy projects to Phase III and beyond. For more information, please visit our website at www.brammerbio.com